Mycobacterium Citations List: May, 2021

Literature Citations

1. Design, in-Silico Study and Biological Evaluation of Newly Synthesized 3-Chlorobenzofuran Congeners as Antitubercular Agents. Abdullah, M.M., N.A. Siddiqui, R.A. Mothana, F.A. Nasr, A.J. Al-Rehaily, O.M. Almarfadi, S. Karim, K. Haider, M.R. Haider, and M.S. Yar. Arabian Journal of Chemistry, 2021. 14(4): 103034. ISI[000636912200007].
[WOS]. TB_05_2021.

2. Dumulmycin, an Antitubercular Bicyclic Macrolide from a Riverine Sediment-derived Streptomyces sp. An, J.S., B. Shin, T.H. Kim, S. Hwang, Y.H. Shin, J. Cui, Y.E. Du, J. Yi, S.J. Nam, S. Hong, J. Shin, J. Jang, Y.J. Yoon, and D.C. Oh. Organic Letters, 2021. 23(9): p. 3359-3363. PMID[33885319].
[PubMed]. TB_05_2021.

3. Stereoselective Synthesis and Discovery of Novel Spirooxindolopyrrolidine Engrafted Indandione Heterocyclic Hybrids as Antimycobacterial Agents. Arumugam, N., A.I. Almansour, R.S. Kumar, V. Siva Krishna, D. Sriram, and N. Dege. Bioorganic Chemistry, 2021. 110: 104798. PMID[33735710].
[PubMed]. TB_05_2021.

4. Synthesis, Antimicrobial and Anti-tubercular Activity Study of N-(Substituted-benzyl)-4-(trifluoromethyl)thiazole-2-sulfonamide and 2-(N-(Substituted-benzyl)sulfamoyl)thiazole-4-carboxylic acid. Bhujbal, N., D. Gaikwad, Y. Jagdale, and C. Pawar. Journal of the Chinese Chemical Society. ISI[000639755500001].
[WOS]. TB_05_2021.

5. Antimicrobial Chlorinated carbazole Alkaloids from the Sponge-associated Actinomycete Streptomyces diacarni LHW51701. Cheng, Y.J., N.N. Chen, J. Li, J.C. Su, J.Y. Yang, C.X. Zhang, H.W. Lin, and Y.J. Zhou. Chinese Journal of Chemistry, 2021. 39(5): p. 1188-1192. ISI[000639405200001].
[WOS]. TB_05_2021.

6. Evaluation of the Anti-mycobacterial Activity of Newly Synthesized (S)-N-(3-(2-Fluoro-4'-(2-amino-4-thiazolyl)biphenyl-4-yl)-2-oxo-1,3-oxazolidie-5-ylmethyl) acetamide Derivative in Vitro and in Mycobacterium marinum-infected Zebrafish. Ding, X., Y. Wu, A. Tong, B. Sun, Y. Zhao, and Y. Jiang. Japanese Journal of Infectious Diseases, 2021. 74(3): p. 245-248. PMID[33132296].
[PubMed]. TB_05_2021.

7. Design, Synthesis, in Silico, and in Vitro Evaluation of 3-Phenylpyrazole acetamide Derivatives as Antimycobacterial Agents. Gaikwad, N.B., K. Nirmale, S.K. Sahoo, M.N. Ahmad, G. Kaul, M. Shukla, S. Nanduri, A. Das Gupta, S. Chopra, and M.V. Yaddanapudi. Archiv der Pharmazie, 2021. 354(5): e2000349. PMID[33351199].
[PubMed]. TB_05_2021.

8. Novel Trifluoromethyl pyrimidinone Compounds with Activity against Mycobacterium tuberculosis. Hembre, E., J.V. Early, J. Odingo, C. Shelton, O. Anoshchenko, J. Guzman, L. Flint, D. Dennison, M.B. McNeil, A. Korkegian, Y. Ovechkina, P. Ornstein, T. Masquelin, P.A. Hipskind, and T. Parish. Frontiers in Chemistry, 2021. 9: 613349. PMID[33996738]. PMCID[PMC8117417].
[PubMed]. TB_05_2021.

9. Synthesis and Antimicrobial Study of Organoiridium amido-sulfadoxine Complexes. Kotze, T.J., S. Duffy, V.M. Avery, A. Jordaan, D.F. Warner, L. Loots, G.S. Smith, and P. Chellan. Inorganica Chimica Acta, 2021. 517: 120175. ISI[000641969900003].
[WOS]. TB_05_2021.

10. Structure Based Design, Synthesis and Evaluation of New Thienopyrimidine Derivatives as Anti-bacterial Agents. Malasala, S., A. Polomoni, M.N. Ahmad, M. Shukla, G. Kaul, A. Dasgupta, S. Chopra, and S. Nanduri. Journal of Molecular Structure, 2021. 1234: 130168. ISI[000637751200008].
[WOS]. TB_05_2021.

11. Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. Muñoz-Muñoz, L., C. Shoen, G. Sweet, A. Vitoria, T.J. Bull, M. Cynamon, C.J. Thompson, and S. Ramón-García. Antibiotics, 2021. 10(4): 381. PMID[33916775]. PMCID[PMC8066277].
[PubMed]. TB_05_2021.

12. Synthesis and Biological Evaluation of Novel Benzhydrylpiperazine-coupled Nitrobenzenesulfonamide Hybrids. Murthy, V.S., Y. Tamboli, V.S. Krishna, D. Sriram, F.X. Zhang, G.W. Zamponi, and V. Vijayakumar. ACS Omega, 2021. 6(14): p. 9731-9740. PMID[33869953]. PMCID[PMC8047747].
[PubMed]. TB_05_2021.

13. Comparative in Vitro Susceptibility of a Novel Fluoroquinolone Antibiotic Candidate WFQ-228, Levofloxacin, and Moxifloxacin against Mycobacterium tuberculosis. Qiao, M., W. Ren, H. Guo, F. Huo, Y. Shang, Y. Wang, M. Gao, and Y. Pang. International Journal of Infectious Diseases, 2021. 106: p. 295-299. PMID[33864922].
[PubMed]. TB_05_2021.

14. Effects of Tafenoquine against Active, Dormant and Resistant Mycobacterium tuberculosis. Sidrônio, M.G.S., A. Castelo Branco, B.L. Abbadi, F. Macchi, M.D. Silveira, G.A. Lock, T.D. Costa, D.M. de Araújo, S. Cibulski, C.V. Bizarro, P. Machado, L.A. Basso, and V.S. Rodrigues-Junior. Tuberculosis, 2021. 128: 102089. PMID[34004588].
[PubMed]. TB_05_2021.

15. Growth-inhibitory Effects of Tris-(1,10-phenanthroline) iron (II) against Mycobacterium tuberculosis in Vitro and in Vivo. Solcia, M.C., D.L. Campos, J.A. Grecco, C.S. Paiva Silva, P. Bento da Silva, I. Cristiane da Silva, A.P. Balduino da Silva, J. Silva, F.B. Oda, A. Gonzaga Dos Santos, and F.R. Pavan. Tuberculosis, 2021. 128: 102087. PMID[34022507].
[PubMed]. TB_05_2021.

16. Discovery of Novel Thiophene-arylamide Derivatives as Dpre1 Inhibitors with Potent Antimycobacterial Activities. Wang, P., S.M. Batt, B. Wang, L. Fu, R. Qin, Y. Lu, G. Li, G.S. Besra, and H. Huang. Journal of Medicinal Chemistry, 2021. 64(9): p. 6241-6261. PMID[33852302]. PMCID[PMC8154581].
[PubMed]. TB_05_2021.

Patent Citations

17. Use of 3,4-Diarylpyrazoles as Antibacterial Agents. Wells, J. and N. Velikova. Patent. 2021. 2019-211619 3827825: 60pp.
[Patent]. TB_05_2021.